electroCore Announces Full Year 2024 Financial Results
12 mars 2025 16h05 HE
|
electroCore, Inc.
Record full year 2024 net sales of $25.2 million increased 57% over $16.0 million for the full year 2023 driven by 85% annual growth of Rx gammaCoreTM in the United States Department of Veteran...
electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2024 Financial Results on Wednesday, March 12, 2025
06 mars 2025 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report its financial...
electroCore to Participate at Upcoming Investor Conferences
05 mars 2025 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., March 05, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate...
Spark Biomedical Partners With Air Force To Launch Trial Testing Innovative Solution to Motion Sickness and Spatial Disorientation
20 févr. 2025 09h37 HE
|
Spark Biomedical
Dallas, TX, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a global leader in wearable neurostimulation technology, announces an innovative study to explore the effectiveness of transcutaneous...
electroCore’s Truvaga™ Now Available on Amazon®
19 févr. 2025 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., Feb. 19, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that its flagship wellness...
electroCore Expands Intellectual Property Portfolio
06 févr. 2025 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received two patent...
electroCore to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
04 févr. 2025 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today its participation in the 12th...
electroCore Expands Intellectual Property Portfolio
07 janv. 2025 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received five patent...
electroCore to Acquire NeuroMetrix, Gaining Access to its Quell Platform and Positioning Itself as a Significant Player in Non-Invasive Bioelectronic Medicine and Wellness
17 déc. 2024 16h05 HE
|
electroCore, Inc.
The Quell® platform will strengthen our position as a significant player in the bioelectronic health and wellness sector Company to discuss acquisition and host investor Q&A in a webcast today at...
electroCore’s Truvaga™ Plus Wins Woman’s World Magazine 50 over 50 Award
20 nov. 2024 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., Nov. 20, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, is proud to announce that its flagship wellness...